Pilot studies to develop small molecule inhibitors and degraders targeting Henipavirus
- Funded by Novo Nordisk Foundation
- Total publications:0 publications
Grant number: N/A
Grant search
Key facts
Disease
Infection caused by Nipah virusStart & end year
2022Known Financial Commitments (USD)
$2,695.47Funder
Novo Nordisk FoundationResearch Location
United States of AmericaLead Research Institution
Stanford UniversityResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
Pre-clinical studiesSpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable